Metabolic and Inflammatory Response in Post-Traumatic Stress Disorder (PTSD): A Systematic Review on Peripheral Neuroimmune Biomarkers

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2023 Feb 25

PMID 36833633

Authors

Valerio DellOste

Sara Fantasia

Davide Gravina

Lionella Palego

Laura Betti

Liliana DellOsso

Gino Giannaccini

Claudia Carmassi

Affiliations

Soon will be listed here.

Abstract

Several heterogeneous pathophysiology pathways have been hypothesized for being involved in the onset and course of Post-Traumatic Stress Disorder (PTSD). This systematic review aims to summarize the current evidence on the role of inflammation and immunological dysregulations in PTSD, investigating possible peripheral biomarkers linked to the neuroimmune response to stress. A total of 44 studies on the dysregulated inflammatory and metabolic response in subjects with PTSD with respect to controls were included. Eligibility criteria included full-text publications in the English language, human adult samples, studies involving both subjects with a clinical diagnosis of PTSD and a healthy control group. The research was focused on specific blood neuroimmune biomarkers, namely IL-1β, TNF-α, IL-6 and INF-γ, as well as on the potential harmful role of reduced antioxidant activity (involving catalase, superoxide dismutase and glutathione peroxidase). The possible role of the inflammatory-altered tryptophan metabolism was also explored. The results showed conflicting data on the role of pro-inflammatory cytokines in individuals with PTSD, and a lack of study regarding the other mediators investigated. The present research suggests the need for further studies in human samples to clarify the role of inflammation in the pathogenesis of PTSD, to define potential peripheral biomarkers.

Citing Articles

Network analysis of PTSD symptoms following childbirth and comorbid conditions among women with sexual trauma history.

Hamlett G, McGhie S, Dishy G, Chan S, McNally R, Dekel S Arch Womens Ment Health. 2025; .

PMID: 40072580 DOI: 10.1007/s00737-025-01570-5.

Genetic and peripheral biomarkers of comorbid posttraumatic stress disorder and traumatic brain injury: a systematic review.

Cowansage K, Nair R, Lara-Ruiz J, Berman D, Boyd C, Milligan T Front Neurol. 2025; 16:1500667.

PMID: 39931547 PMC: 11807831. DOI: 10.3389/fneur.2025.1500667.

Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations.

Demurtas S, Cena H, Benazzo M, Gabanelli P, Porcelli S, Preda L J Clin Med. 2024; 13(20).

PMID: 39458125 PMC: 11509296. DOI: 10.3390/jcm13206176.

Glutathione in HIV-Associated Neurocognitive Disorders.

Erdos T, Masuda M, Venketaraman V Curr Issues Mol Biol. 2024; 46(6):5530-5549.

PMID: 38921002 PMC: 11202908. DOI: 10.3390/cimb46060330.

Fetal Sex as Moderating Factor for the Relationship Between Maternal Childhood Trauma and Salivary Kynurenic Acid and Tryptophan in Pregnancy: A Pilot Study.

Pedraz-Petrozzi B, Lamade E, Marszalek-Grabska M, Trzpil A, Lindner O, Meininger P Int J Tryptophan Res. 2024; 17:11786469241244603.

PMID: 38660592 PMC: 11041113. DOI: 10.1177/11786469241244603.

References

Oglodek E . Evaluation of ADMA, carbonyl groups, CAT and NKA in depressed patients with and without posttraumatic stress disorder. Pharmacol Rep. 2017; 69(4):730-737. DOI: 10.1016/j.pharep.2017.02.015. View

Palego L, Giannaccini G, Betti L . Neuroendocrine Response to Psychosocial Stressors, Inflammation Mediators and Brain-periphery Pathways of Adaptation. Cent Nerv Syst Agents Med Chem. 2020; 21(1):2-19. DOI: 10.2174/1871524920999201214231243. View

Kim B, Fonda J, Hauger R, Pinna G, Anderson G, Valovski I . Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD. Neurobiol Stress. 2020; 12:100220. PMC: 7231970. DOI: 10.1016/j.ynstr.2020.100220. View

Katrinli S, Oliveira N, Felger J, Michopoulos V, Smith A . The role of the immune system in posttraumatic stress disorder. Transl Psychiatry. 2022; 12(1):313. PMC: 9352784. DOI: 10.1038/s41398-022-02094-7. View

Lindqvist D, Dhabhar F, Mellon S, Yehuda R, Grenon S, Flory J . Increased pro-inflammatory milieu in combat related PTSD - A new cohort replication study. Brain Behav Immun. 2016; 59:260-264. DOI: 10.1016/j.bbi.2016.09.012. View

Jergovic M, Tomicevic M, Vidovic A, Bendelja K, Savic A, Vojvoda V . Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 54:275-83. DOI: 10.1016/j.pnpbp.2014.06.010. View

Spivak B, Shohat B, Mester R, Avraham S, Gil-ad I, Bleich A . Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry. 1997; 42(5):345-8. DOI: 10.1016/S0006-3223(96)00375-7. View

Passos I, Vasconcelos-Moreno M, Costa L, Kunz M, Brietzke E, Quevedo J . Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015; 2(11):1002-12. DOI: 10.1016/S2215-0366(15)00309-0. View

Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M . Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry. 2013; 13:40. PMC: 3574862. DOI: 10.1186/1471-244X-13-40. View

10.

Baker D, Ekhator N, Kasckow J, Hill K, Zoumakis E, Dashevsky B . Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation. 2002; 9(4):209-17. DOI: 10.1159/000049028. View

11.

Dalgard C, Eidelman O, Jozwik C, Olsen C, Srivastava M, Biswas R . The MCP-4/MCP-1 ratio in plasma is a candidate circadian biomarker for chronic post-traumatic stress disorder. Transl Psychiatry. 2017; 7(2):e1025. PMC: 5438024. DOI: 10.1038/tp.2016.285. View

12.

Levin S, Godukhin O . Modulating Effect of Cytokines on Mechanisms of Synaptic Plasticity in the Brain. Biochemistry (Mosc). 2017; 82(3):264-274. DOI: 10.1134/S000629791703004X. View

13.

Oliveira J, Wiener C, Jansen K, Portela L, Lara D, Souza L . Serum levels of interleukins IL-6 and IL-10 in individuals with posttraumatic stress disorder in a population-based sample. Psychiatry Res. 2017; 260:111-115. DOI: 10.1016/j.psychres.2017.11.061. View

14.

Jergovic M, Bendelja K, Savic Mlakar A, Vojvoda V, Aberle N, Jovanovic T . Circulating levels of hormones, lipids, and immune mediators in post-traumatic stress disorder - a 3-month follow-up study. Front Psychiatry. 2015; 6:49. PMC: 4396135. DOI: 10.3389/fpsyt.2015.00049. View

15.

Koenen K, Ratanatharathorn A, Ng L, McLaughlin K, Bromet E, Stein D . Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med. 2017; 47(13):2260-2274. PMC: 6034513. DOI: 10.1017/S0033291717000708. View

16.

Karanikas E . Psychologically Traumatic Oxidative Stress; A Comprehensive Review of Redox Mechanisms and Related Inflammatory Implications. Psychopharmacol Bull. 2021; 51(4):65-86. PMC: 8601764. View

17.

Levine A, Levine L, Levine T . Posttraumatic stress disorder and cardiometabolic disease. Cardiology. 2013; 127(1):1-19. DOI: 10.1159/000354910. View

18.

Borovac Stefanovic L, Kalinic D, Mimica N, Ljubic B, Aladrovic J, Mandelsamen Perica M . Oxidative status and the severity of clinical symptoms in patients with post-traumatic stress disorder. Ann Clin Biochem. 2014; 52(Pt 1):95-104. DOI: 10.1177/0004563214528882. View

19.

Wang W, Wang L, Xu H, Cao C, Liu P, Luo S . Characteristics of pro- and anti-inflammatory cytokines alteration in PTSD patients exposed to a deadly earthquake. J Affect Disord. 2019; 248:52-58. DOI: 10.1016/j.jad.2019.01.029. View

20.

Tucker P, Ruwe W, Masters B, Parker D, Hossain A, Trautman R . Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry. 2004; 56(2):121-8. DOI: 10.1016/j.biopsych.2004.03.009. View